AWS’s new accelerator team will focus on health equity and more digital health

Amazon Web Services It is now accepting applications for its latest team of healthcare accelerators, which will aim to improve health outcomes for disadvantaged communities this year.

The Accelerator will take over 10 startups focused on increasing access to healthcare, reducing inequalities by managing social determinants of health, and using data for equity in healthcare. Companies will receive affiliation with venture capital firms, business planning assistance, AWS training, opportunities to work with AWS partners, and market planning.

This is the hall This is the second year of AWS Accelerator in the United States, and it recently launched a UK-based program that began in March.

Applications apply July 1, and the program will begin in late August.

Presumably, an initiative of the biomedical-data company nference, announcing that it has received the FDA Breakthrough Device designation for its ECG-based AI algorithm designed for the early detection of pulmonary hypertension.

The The Breakthrough Device designation is not a marketing approval from the FDA, but it aims to expedite the review of products that may assist in the treatment of debilitating or life-threatening conditions.

If the algorithm is approved in the future, speculation suggests it could be downloaded to a physician’s device, such as a smartphone or laptop, or access to the cloud via an EHR or ECG data management system.

“Electrophysiology waveforms have a lot of potential for undiagnosed diseases prior to their natural history, especially in situations where early diagnosis and therapeutic interventions can prolong survival and improve quality of life,” said Venky Soundrajan, co-founder And the chief scientific officer says. In a statement.

“The FDA’s breakthrough device designation for the supposed PH early detection algorithm is one step ahead for the ECG AI field as a whole, and more importantly, a huge leap forward for PH patients.”

AI-enabled imaging company Aidoc and Gleamer are partnering to integrate the next BoneView tool for X-ray on Aidoc’s platform.

Glimmer software Earlier this year, the FDA obtained 510 (k) clearance from X-rays to detect possible fractures, sending the results to radiologists for confirmation. Meanwhile, Aidoc recently received clearance for its pneumothorax-detection tool using X-rays.

A statement from Gleamer’s Solution said: “Bone trauma X-rays are responsible for a high percentage of hospital imaging volumes. Gleamer’s Solution is an important step in our mission to provide comprehensive coverage with AI

“Driven by the enterprise-grade scalability of our AI platform, Gleamer’s solution is another invaluable addition to our industry-leading AI solution suite that, collectively, strengthens the healthcare system to improve patient outcomes across multiple methods and service lines within the hub.” Model. “

Leave a Reply

Your email address will not be published.